Cover Image
Market Research Report
Product code 
1044265

Market Study on Generic Oncology Drugs: Market Players to Benefit from Diversification of Product Portfolio

Published: | Persistence Market Research | 176 Pages | Delivery time: 2-3 business days

Price

Back to Top
Market Study on Generic Oncology Drugs: Market Players to Benefit from Diversification of Product Portfolio
Published: November 12, 2021
Persistence Market Research
Content info: 176 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

Scope of the Report:

Persistence Market Research recently published a revised report on the global generic oncology drugs market. The report provides detailed valuation on key market dynamics, such as the drivers, trends, opportunities, and restraints, along with detailed information about the market structure. This research report presents exclusive facts and figures about how the global generic oncology drugs market will grow over the forecast period of 2021 to 2031.

Key indicators of market background, such as value chain analysis and supply chain, compounded annual growth rate (CAGR), and year-on-year (Y-o-Y) growth of the market are explained in Persistence Market Research's study in a comprehensive manner. This information can help readers understand the quantitative development projections of the generic oncology drugs market over the forecast period.

The study is relevant for stakeholders in the global generic oncology drugs market, as well as manufacturers, distributors, suppliers, and investors, as it can help them understand applicable strategies to grow in the market. Stakeholders, investors, industry experts, researchers, and journalists, as well as business researchers in market can leverage the information and statistics presented in research report.

The report includes facts & figures related to the micro- as well as macro-economic factors that are impacting the growth of the market. The study also offers actionable insights based on the future trends in the market. Furthermore, domestic players and new entrants in the market can also use the information presented in this report to make business decisions and gain momentum in the market.

Key Segmentation:

Persistence Market Research's study on the global generic oncology drugs market is divided into four significant segments - molecule type, route of administration, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters related to these categories.

Molecule Type

  • Large Molecules
  • Small Molecules

Route of Administration

  • Oral
  • Parenteral

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Managed Care Institutions

Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excl. China and Japan
  • China
  • Japan
  • MEA

Key Questions Answered in Report:

  • Which region is anticipated to hold a prominent market share over the forecast period?
  • What will be the key driving factors propelling the demand for generic oncology drugs during the forecast period?
  • How current trends will impact the global generic oncology drugs industry?
  • Who are significant market participants in the market?
  • What are the crucial strategies of prominent players in the global generic oncology drugs market to upscale their positions in this landscape?

Research Methodology

In Persistence Market Research's research report, exclusive research methodology is utilized to conduct comprehensive research on the development of the global generic oncology drugs market, and reach conclusions on the future growth factors of the market. In this research methodology, secondary and primary research is utilized by analysts to ensure the precision and reliability of the conclusions.

Secondary resources are referred by analysts during the evaluation of the global generic oncology drugs market study, which comprise facts and figures from white papers, trade journals, and external and internal databases. Analysts have thoroughly interviewed several industry experts, such as sales supervisors, sales operation managers, product portfolio managers, senior managers, market intelligence managers, marketing/product managers, engineering managers, and production managers to provide insightful information.

Comprehensive information acquired from primary and secondary resources is validated from companies operating in the global generic oncology drugs market, to make Persistence Market Research's projections on the growth prospects of the market more accurate and reliable.

Product Code: PMRREP25480

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. FMI Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Taxonomy
  • 2.2. Market Definition

3. Generic Oncology Drugs Market Opportunity Analysis

  • 3.1. Macro-Economic Factors
  • 3.2. Opportunity Analysis

4. Market Background

  • 4.1. PESTLE Analysis
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Trends
  • 4.3. Regulatory Scenario

5. Key Inclusions

  • 5.1. Generic Oncology Drugs Pipeline

6. North America Generic Oncology Drugs Market Analysis 2016-2020 and Forecast 2021-2031

  • 6.1. Introduction
  • 6.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2020
    • 6.2.1. U.S.
    • 6.2.2. Canada
  • 6.3. Market Size (US$ Mn) Forecast By Country, 2021-2031
  • 6.4. Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
    • 6.4.1. Large Molecule
    • 6.4.2. Small Molecule
  • 6.5. Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
  • 6.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016-2020
    • 6.6.1. Oral
    • 6.6.2. Parenteral
  • 6.7. Market Size (US$ Mn) Forecast By Route of Administration, 2021-2031
  • 6.8. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
    • 6.8.1. Hospital Pharmacy
    • 6.8.2. Retail Pharmacy
    • 6.8.3. Online Pharmacy
    • 6.8.4. Managed Care Institutions
  • 6.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
  • 6.10. Drivers and Restraints: Impact Analysis
  • 6.11. Market Attractiveness Analysis
    • 6.11.1. By Country
    • 6.11.2. By Molecule Type
    • 6.11.3. By Route of Administration
    • 6.11.4. By Distribution Channel

7. Western Europe Generic Oncology Drugs Market Analysis 2016-2020 and Forecast 2021-2031

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2020
    • 7.2.1. Germany
    • 7.2.2. U.K
    • 7.2.3. France
    • 7.2.4. Italy
    • 7.2.5. Spain
    • 7.2.6. Rest of Western Europe
  • 7.3. Market Size (US$ Mn) Forecast By Country, 2021-2031
  • 7.1. Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
    • 7.1.1. Large Molecule
    • 7.1.2. Small Molecule
  • 7.2. Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
  • 7.3. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016-2020
    • 7.3.1. Oral
    • 7.3.2. Parenteral
  • 7.4. Market Size (US$ Mn) Forecast By Route of Administration, 2021-2031
  • 7.5. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
    • 7.5.1. Hospital Pharmacy
    • 7.5.2. Retail Pharmacy
    • 7.5.3. Online Pharmacy
    • 7.5.4. Managed Care Institutions
  • 7.6. Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
  • 7.7. Drivers and Restraints: Impact Analysis
  • 7.8. Market Attractiveness Analysis
    • 7.8.1. By Country
    • 7.8.2. By Molecule Type
    • 7.8.3. By Route of Administration
    • 7.8.4. By Distribution Channel

8. Eastern Europe Generic Oncology Drugs Market Analysis 2016-2020 and Forecast 2021-2031

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2020
    • 8.2.1. Russia
    • 8.2.2. Poland
    • 8.2.3. Rest of Eastern Europe
  • 8.3. Market Size (US$ Mn) Forecast By Country, 2021-2031
  • 8.1. Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
    • 8.1.1. Large Molecule
    • 8.1.2. Small Molecule
  • 8.2. Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
  • 8.3. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016-2020
    • 8.3.1. Oral
    • 8.3.2. Parenteral
  • 8.4. Market Size (US$ Mn) Forecast By Route of Administration, 2021-2031
  • 8.5. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
    • 8.5.1. Hospital Pharmacy
    • 8.5.2. Retail Pharmacy
    • 8.5.3. Online Pharmacy
    • 8.5.4. Managed Care Institutions
  • 8.6. Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
  • 8.7. Drivers and Restraints: Impact Analysis
  • 8.8. Market Attractiveness Analysis
    • 8.8.1. By Country
    • 8.8.2. By Molecule Type
    • 8.8.3. By Route of Administration
    • 8.8.4. By Distribution Channel

9. Latin America Generic Oncology Drugs Market Analysis 2016-2020 and Forecast 2021-2031

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2020
    • 9.2.1. Brazil
    • 9.2.2. Mexico
    • 9.2.3. Rest of Latin America
  • 9.3. Market Size (US$ Mn) Forecast By Country, 2021-2031
  • 9.1. Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
    • 9.1.1. Large Molecule
    • 9.1.2. Small Molecule
  • 9.2. Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
  • 9.3. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016-2020
    • 9.3.1. Oral
    • 9.3.2. Parenteral
  • 9.4. Market Size (US$ Mn) Forecast By Route of Administration, 2021-2031
  • 9.5. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
    • 9.5.1. Hospital Pharmacy
    • 9.5.2. Retail Pharmacy
    • 9.5.3. Online Pharmacy
    • 9.5.4. Managed Care Institutions
  • 9.6. Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
  • 9.7. Drivers and Restraints: Impact Analysis
  • 9.8. Market Attractiveness Analysis
    • 9.8.1. By Country
    • 9.8.2. By Molecule Type
    • 9.8.3. By Route of Administration
    • 9.8.4. By Distribution Channel

10. Asia Pacific Excluding China & Japan Generic Oncology Drugs Market Analysis 2016-2020 and Forecast 2021-2031

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2020
    • 10.2.1. India
    • 10.2.2. Australia and New Zealand
    • 10.2.3. ASEAN
    • 10.2.4. Rest of APECJ
  • 10.3. Market Size (US$ Mn) Forecast By Country, 2021-2031
  • 10.4.Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
    • 10.4.1. Large Molecule
    • 10.4.2. Small Molecule
  • 10.5. Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
  • 10.6.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016-2020
    • 10.6.1. Oral
    • 10.6.2. Parenteral
  • 10.7.Market Size (US$ Mn) Forecast By Route of Administration, 2021-2031
  • 10.8.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
    • 10.8.1. Hospital Pharmacy
    • 10.8.2. Retail Pharmacy
    • 10.8.3. Online Pharmacy
    • 10.8.4. Managed Care Institutions
  • 10.9.Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
  • 10.10. Drivers and Restraints: Impact Analysis
  • 10.11. Market Attractiveness Analysis
    • 10.11.1. By Country
    • 10.11.2. By Molecule Type
    • 10.11.3. By Route of Administration
    • 10.11.4. By Distribution Channel

11. China Generic Oncology Drugs Market Analysis 2016-2020 and Forecast 2021-2031

  • 11.1. Introduction
  • 11.1.Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
    • 11.1.1. Large Molecule
    • 11.1.2. Small Molecule
  • 11.2. Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
  • 11.3.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016-2020
    • 11.3.1. Oral
    • 11.3.2. Parenteral
  • 11.4.Market Size (US$ Mn) Forecast By Route of Administration, 2021-2031
  • 11.5.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
    • 11.5.1. Hospital Pharmacy
    • 11.5.2. Retail Pharmacy
    • 11.5.3. Online Pharmacy
    • 11.5.4. Managed Care Institutions
  • 11.6.Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
  • 11.7. Drivers and Restraints: Impact Analysis
  • 11.8. Market Attractiveness Analysis
    • 11.8.1. By Molecule Type
    • 11.8.2. By Route of Administration
    • 11.8.3. By Distribution Channel

12. Japan Generic Oncology Drugs Market Analysis 2016-2020 and Forecast 2021-2031

  • 12.1. Introduction
  • 12.1.Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
    • 12.1.1. Large Molecule
    • 12.1.2. Small Molecule
  • 12.2. Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
  • 12.3.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016-2020
    • 12.3.1. Oral
    • 12.3.2. Parenteral
  • 12.4.Market Size (US$ Mn) Forecast By Route of Administration, 2021-2031
  • 12.5.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
    • 12.5.1. Hospital Pharmacy
    • 12.5.2. Retail Pharmacy
    • 12.5.3. Online Pharmacy
    • 12.5.4. Managed Care Institutions
  • 12.6.Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
  • 12.7. Drivers and Restraints: Impact Analysis
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Molecule Type
    • 12.8.2. By Route of Administration
    • 12.8.3. By Distribution Channel

13. Middle East and Africa Generic Oncology Drugs Market Analysis 2016-2020 and Forecast 2021-2031

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Country, 2016-2020
    • 13.2.1. GCC Countries
    • 13.2.2. South Africa
    • 13.2.3. Rest of Middle East and Africa
  • 13.3. Market Size (US$ Mn) Forecast By Country, 2021-2031
  • 13.1.Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
    • 13.1.1. Large Molecule
    • 13.1.2. Small Molecule
  • 13.2. Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
  • 13.3.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016-2020
    • 13.3.1. Oral
    • 13.3.2. Parenteral
  • 13.4.Market Size (US$ Mn) Forecast By Route of Administration, 2021-2031
  • 13.5.Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
    • 13.5.1. Hospital Pharmacy
    • 13.5.2. Retail Pharmacy
    • 13.5.3. Online Pharmacy
    • 13.5.4. Managed Care Institutions
  • 13.6.Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
  • 13.7. Drivers and Restraints: Impact Analysis
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Country
    • 13.8.2. By Molecule Type
    • 13.8.3. By Route of Administration
    • 13.8.4. By Distribution Channel

14. Forecast Factors: Relevance and Impact

15. Forecast Assumptions

16. Competition Analysis

  • 16.1.Competition Dashboard
  • 16.2.Company Deep Dive
    • 16.2.1. Novartis AG
      • 16.2.1.1. Overview
      • 16.2.1.2. Treatment and Application Portfolio
      • 16.2.1.3. Product Footprint
      • 16.2.1.4. Sales Footprint
      • 16.2.1.5. Channel Footprint
      • 16.2.1.6. Strategy
        • 16.2.1.6.1.1 Marketing Strategy
        • 16.2.1.6.1.2. Treatment Strategy
        • 16.2.1.6.1.3. Channel Strategy
    • 16.2.2. Pfizer Inc.
    • 16.2.3. GlaxoSmithKline plc
    • 16.2.4. CELGENE CORPORATION
    • 16.2.5. Teva Pharmaceutical Industries Ltd.
    • 16.2.6. Merck & Company, Inc
    • 16.2.7. Aurobindo Pharma.
    • 16.2.8. Hikma Pharmaceuticals PLC
    • 16.2.9. Mylan N.V.
    • 16.2.10. NATCO Pharma Limited.

17. Global Generic Oncology Drugs Market Analysis 2016-2020 and Forecast 2021-2031 By Region

  • 17.1. Introduction / Key Findings
  • 17.2. Historical Market Size (US$ Mn) Analysis By Region
    • 17.2.1. North America
    • 17.2.2. Western Europe
    • 17.2.3. Eastern Europe
    • 17.2.4. Latin America
    • 17.2.5. Asia Pacific Excluding Japan
    • 17.2.6. Japan
    • 17.2.7. China
    • 17.2.8. Middle East and Africa
  • 17.3. Market Size (US$ Mn) Forecast By Region
  • 17.4. Market Attractiveness Analysis By Region

18. Global Generic Oncology Drugs Market Analysis 2016-2020 and Forecast 2021-2031, By Molecule Type

  • 18.1. Introduction/Key Finding
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis By Molecule Type, 2016-2020
    • 18.2.1. Large Molecule
    • 18.2.2. Small Molecule
  • 18.3.Market Size (US$ Mn) Forecast By Molecule Type, 2021-2031
  • 18.4. Market Attractiveness Analysis By Molecule Type

19. Global Generic Oncology Drugs Market Analysis 2016-2020 and Forecast 2021-2031, By Route Of Administration

  • 19.1.Introduction/Key Finding
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis By Route Of Administration, 2016-2020
    • 19.2.1. Oral
    • 19.2.2. Parenteral
  • 19.3.Market Size (US$ Mn) Forecast By Route Of Administration, 2021-2031
  • 19.4.Market Attractiveness Analysis By Route Of Administration

20. Global Generic Oncology Drugs Market Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

  • 20.1.Introduction/Key Finding
  • 20.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016-2020
    • 20.2.1. Hospital Pharmacy
    • 20.2.2. Retail Pharmacy
    • 20.2.3. Online Pharmacy
    • 20.2.4. Managed Care Institutions
  • 20.3.Market Size (US$ Mn) Forecast By Distribution Channel, 2021-2031
  • 20.4.Market Attractiveness Analysis By Distribution Channel

21. Global Generic Oncology Drugs Market Analysis 2016-2020 and Forecast 2021-2031

  • 21.1.Market Value Share Analysis By All Segment
  • 21.2.Y-o-Y Growth Analysis By All Segment
  • 21.3.Absolute $ Opportunity

22. Assumptions and Acronyms Used

23. Research Methodology

List of Tables

  • Table 01: Generic Oncology Drugs Expected to be Launched by end of 2018
  • Table 02: North America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
  • Table 03: North America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Molecule Type
  • Table 04: North America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
  • Table 05: North America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
  • Table 06: Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
  • Table 07: Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Molecule Type
  • Table 08: Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
  • Table 09: Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
  • Table 10: Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
  • Table 11: Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Molecule Type
  • Table 12: Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
  • Table 13: Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
  • Table 14: Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
  • Table 15: Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Molecule Type
  • Table 16: Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
  • Table 17: Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
  • Table 18: APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
  • Table 19: APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Molecule Type
  • Table 20: APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
  • Table 21: APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
  • Table 22: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Molecule Type
  • Table 23: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
  • Table 24: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
  • Table 25: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Molecule Type
  • Table 26: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
  • Table 27: China Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
  • Table 28: MEA Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country
  • Table 29: MEA Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Molecule Type
  • Table 30: MEA Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
  • Table 31: MEA Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel
  • Table 32: Global Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region
  • Table 33: Global Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Molecule Type
  • Table 34: Global Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Route of Administration
  • Table 35: Global Generic Oncology Drugs Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Distribution Channel

List of Figures

  • Figure 01: Generic Oncology Drugs Market Value Share By Region (2021)
  • Figure 02: Global Generic Oncology Drugs Market Share, By Region (2020)
  • Figure 03: Global Generic Oncology Drugs Market Share, By Molecule Type (2020)
  • Figure 04: Global Generic Oncology Drugs Market Share, By Route of Administration Type (2020)
  • Figure 05: Global Generic Oncology Drugs Market Share, By Distribution Channel (2020)
  • Figure 06: Distribution of Industry Sponsored Clinical Programs for Generic Oncology Drugs, by Phase
  • Figure 07: Number of Active Clinical Programs, by Major Indications
  • Figure 08: Geographical Distribution of Clinical Trials for Meningococcal Vaccines (2020)
  • Figure 09: North America Generic Oncology Drugs Market, Snapshot
  • Figure 10: North America Generic Oncology Drugs Market Value Share, by Country (2020)
  • Figure 11: North America Generic Oncology Drugs Market Value Share, by Molecule Type (2020)
  • Figure 12: North America Generic Oncology Drugs Market Value Share, by Distribution Channel (2020)
  • Figure 13: North America Generic Oncology Drugs Market Value Share, By Route of Administration (2020)
  • Figure 14: North America Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2016-2020
  • Figure 15: North America Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2021-2031
  • Figure 16: North America Generic Oncology Drugs Market Attractiveness Analysis, By Country
  • Figure 17: North America Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 18: North America Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 19: North America Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 20: Latin America Generic Oncology Drugs Market, Snapshot
  • Figure 21: Latin America Generic Oncology Drugs Market Value Share, by Country (2020)
  • Figure 22: Latin America Generic Oncology Drugs Market Value Share, by Molecule Type (2020)
  • Figure 23: Latin America Generic Oncology Drugs Market Value Share, by Distribution Channel (2020)
  • Figure 24: Latin America Generic Oncology Drugs Market Value Share, By Route of Administration (2020)
  • Figure 25: Latin America Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2016-2020
  • Figure 26: Latin America Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2021-2031
  • Figure 27: Latin America Generic Oncology Drugs Market Attractiveness Analysis, By Country
  • Figure 28: Latin America Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 29: Latin America Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 30: Latin America Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 31: Western Europe Generic Oncology Drugs Market, Snapshot
  • Figure 32: Western Europe Generic Oncology Drugs Market Value Share, by Country (2020)
  • Figure 33: Western Europe Generic Oncology Drugs Market Value Share, by Molecule Type (2020)
  • Figure 34: Western Europe Generic Oncology Drugs Market Value Share, by Distribution Channel (2020)
  • Figure 35: Western Europe Generic Oncology Drugs Market Value Share, By Route of Administration (2020)
  • Figure 36: Western Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2016-2020
  • Figure 37: Western Europe Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2021-2031
  • Figure 38: Western Europe Generic Oncology Drugs Market Attractiveness Analysis, By Country
  • Figure 39: Western Europe Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 40: Western Europe Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 41: Western Europe Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 42: Eastern Europe Generic Oncology Drugs Market, Snapshot
  • Figure 43: Eastern Europe Generic Oncology Drugs Market Value Share, by Country (2020)
  • Figure 44: Eastern Europe Generic Oncology Drugs Market Value Share, by Molecule Type (2020)
  • Figure 45: Eastern Europe Generic Oncology Drugs Market Value Share, by Distribution Channel (2020)
  • Figure 46: Eastern Europe Generic Oncology Drugs Market Value Share, By Route of Administration (2020)
  • Figure 47: Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2016-2020
  • Figure 48: Eastern Europe Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2021-2031
  • Figure 49: Eastern Europe Generic Oncology Drugs Market Attractiveness Analysis, By Country
  • Figure 50: Eastern Europe Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 51: Eastern Europe Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 52: Eastern Europe Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 53: APECJ Generic Oncology Drugs Market, Snapshot
  • Figure 54: APECJ Generic Oncology Drugs Market Value Share, by Country (2020)
  • Figure 55: APECJ Generic Oncology Drugs Market Value Share, by Molecule Type (2020)
  • Figure 56: APECJ Generic Oncology Drugs Market Value Share, by Distribution Channel (2020)
  • Figure 57: APECJ Generic Oncology Drugs Market Value Share, By Route of Administration (2020)
  • Figure 58: APECJ Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2016-2020
  • Figure 59: APECJ Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2021-2031
  • Figure 60: APECJ Generic Oncology Drugs Market Attractiveness Analysis, By Country
  • Figure 61: APECJ Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 62: APECJ Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 63: APECJ Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 64: China Generic Oncology Drugs Market, Snapshot
  • Figure 65: China Generic Oncology Drugs Market Value Share, by Molecule Type (2020)
  • Figure 66: China Generic Oncology Drugs Market Value Share, by Route of Administration (2020)
  • Figure 67: China Generic Oncology Drugs Market Value Share, By Distribution Channel (2020)
  • Figure 68: China Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2016-2020
  • Figure 69: China Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2021-2031
  • Figure 70: China Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 71: China Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 72: China Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 73: Japan Generic Oncology Drugs Market, Snapshot
  • Figure 74: Japan Generic Oncology Drugs Market Value Share, By Molecule Type (2020)
  • Figure 75: Japan Generic Oncology Drugs Market Value Share, By Route of Administration (2020)
  • Figure 76: Japan Generic Oncology Drugs Market Value Share, By Distribution Channel (2020)
  • Figure 77: Japan Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2016-2020
  • Figure 78: Japan Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2021-2031
  • Figure 79: China Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 80: China Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 81: China Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 82: Middle East & Africa Generic Oncology Drugs Market, Snapshot
  • Figure 83: MEA Generic Oncology Drugs Market Value Share, by Molecule Type (2020)
  • Figure 84: MEA Generic Oncology Drugs Market Value Share, by Country (2020)
  • Figure 85: MEA Generic Oncology Drugs Market Value Share, by Distribution Channel (2020)
  • Figure 86: MEA Generic Oncology Drugs Market Value Share, By Route of Administration (2020)
  • Figure 87: Middle East & Africa Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2016-2020
  • Figure 88: Middle East & Africa Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2021-2031
  • Figure 89: MEA Generic Oncology Drugs Market Attractiveness Analysis, By Country
  • Figure 90: MEA Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 91: MEA Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 92: MEA Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 93: Global Generic Oncology Drugs Market Attractiveness Analysis, By Region
  • Figure 94: Global Generic Oncology Drugs Market Value Share Analysis, By Region, 2021 & 2031
  • Figure 95: Global Generic Oncology Drugs Market Attractiveness Analysis, By Molecule Type
  • Figure 96: Global Generic Oncology Drugs Market Value Share Analysis, By Molecule Type, 2021 & 2031
  • Figure 97: Global Generic Oncology Drugs Market Attractiveness Analysis, By Route of Administration
  • Figure 98: Global Generic Oncology Drugs Market Value Share Analysis, By Route of Administration, 2021 & 2031
  • Figure 99: Global Generic Oncology Drugs Market Attractiveness Analysis, By Distribution Channel
  • Figure 100: Global Generic Oncology Drugs Market Value Share Analysis, By Distribution Channel, 2021 & 2031
  • Figure 101: Global Generic Oncology Drugs Market Size (US$ Mn) Analysis, 2016-2020
  • Figure 102: Global Generic Oncology Drugs Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2021-2031
  • Figure 103: Global Generic Oncology Drugs Market Absolute $ Opportunity, 2016-2020